Anda belum login :: 07 May 2025 07:14 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Effect of Adiunctive Pramlintide Treatment on Treatment Satisfaction in Patients With Type I Diabetes
Oleh:
Marrero, David G.
;
Crean, John
;
Zhang, Bei
;
Kellmeyer, Terrie
;
Gloster, Maurice
;
Herrmann, Kathrin
;
Rubin, Richard
;
Fineberg, Naomi
;
Kolterman, Orville
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Diabetes Care vol. 30 no. 02 (Feb. 2007)
,
page 210.
Ketersediaan
Perpustakaan FK
Nomor Panggil:
D05.K.2007.01
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
OBJECTIVE - To assess the effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes treated with intensive insulin regimens. RESEARCH DESIGN AND METHODS - Intensively treated (multiple daily injection [MOl] or continuous subcutaneous insulin infusion [CSII] pump therapy) patients with type 1 diabetes completed a study-specific treatment satisfaction questionnaire following 29 weeks of either placebo (n = 136) or pramlintide (n = 130) treatment in a double-blind, noninferiority pramlintide dose titration trial. End points included patient reponed outcomes, their relationship to insulin treatment regimen, AIC, weight, and insulin use. RESULTS - Pramlintide-treated patients reponed greater treatment satisfaction in most questionnaire responses. Treatment satisfaction was similar for pramlintide-treated patients regardless of intensive insulin regimens (MOl versus CSII). Mean AIC was reduced to a similar degree in both pramlintide- (-0.39 :!:: 0.07%) and placebo-treated (-0.45 :!:: 0.07%) patients. However, pramlintide treatment was associated with reductions in mean body weight (-1.50 :!:: 0.33 kg; P < 0.0001) and mealtime insulin use (-19.05 :!:: 5.17%; P < 0.005) over 29 weeks, while placebo treatment resulted in weight gain 0.28 :!:: 0.25 kg) and a smaller reduction in mealtime insulin use (- 2.20 :!:: 3.33%). CONCLUSIONS - Despite similar reductions in AIC, pramlintide treatment resulted in greater treatment satisfaction compared with placebo treatment. This was independent of insulin delivery method.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0 second(s)